[1] RUEDAS-TORRES I, RODRÍGUEZ-GÓMEZ I M, SÁNCHEZ-CARVAJAL J M, et al.The jigsaw of PRRSV virulence[J]. Veterinary Microbiology, 2021, 260:109168. [2] 张哲玮, 贝为成.猪繁殖与呼吸综合征的研究进展及防控措施[J].猪业科学, 2021, 38(11):78-82. ZHANG Z W, BEI W C.Research progress and prevention and control measures of porcine reproductive and respiratory syndrome[J].Swine Industry Science, 2021, 38(11):78-82.(in Chinese). [3] RISSER J, ACKERMAN M, EVELSIZER R, et al.Porcine reproductive and respiratory syndrome virus genetic variability a management and diagnostic dilemma[J]. Virology Journal, 2021, 18(1):1-12. [4] 邓同炜, 薛亚南, 卢建洲, 等.猪繁殖与呼吸综合征病毒、猪圆环病毒2型与副猪嗜血杆菌混合感染的诊断及病原分析[J].中国畜牧兽医, 2020, 47(10):3401-3409. DENG T W, XUE Y N, LU J Z, et al.Diagnosis and pathogen analysis of mixed infection of Porcine reproductive and respiratory syndrome virus, Porcine circovirus type 2 and Haemophilus parasuis[J].China Animal Husbandry & Veterinary Medicine, 2020, 47(10):3401-3409.(in Chinese). [5] LYOO Y S.Porcine reproductive and respiratory syndrome virus vaccine does not fit in classical vaccinology[J]. Clinical and Experimental Vaccine Research (Seoul), 2015, 4(2):159-165. [6] BAMAL D, SINGH A, CHAUDHARY G, et al.Silver nanoparticles biosynthesis, characterization, antimicrobial activities, applications, cytotoxicity and safety issues:An updated review[J]. Nanomaterials, 2021, 11(8):2086-2126. [7] MISIRLI G M, SRIDHARAN K, ABRANTES S M P.A review on nanostructured silver as a basic ingredient in medicine:Physicochemical parameters and characterization[J]. Beilstein Journal of Nanotechnology, 2021, 12(1):440-461. [8] DJELLABI R, BASILICO N, DELBUE S, et al.Oxidative inactivation of SARS-CoV-2 on photoactive AgNPs@TiO2 ceramic tiles[J]. International Journal of Molecular Sciences, 2021, 22(16):8836-8847. [9] PILAQUINGA F, MOREY J, TORRES M, et al.Silver nanoparticles as a potential treatment against SARS-CoV-2:A review[J]. WIREs Nanomedicine and Nanobiotechnology, 2021, 13(5):1707-1726. [10] LARA H H, AYALA-NUNEZ N V, IXTEPAN-TURRENT L, et al.Mode of antiviral action of silver nanoparticles against HIV-1[J]. Journal of Nanobiotechnology, 2010, 8(1):1-10. [11] KRZYZOWSKA M, CHODKOWSKI M, JANICKA M, et al.Lactoferrin-functionalized noble metal nanoparticles as new antivirals for HSV-2 infection[J]. Microorganisms, 2022, 10(1):110-128. [12] 尹俭俭, 李秀景, 郑丛龙.纳米银体外抗新城疫病毒作用及机制研究[J].中国家禽, 2013, 35(15):14-17. YIN J J, LI X J, ZHENG C L.Mechanisms and inhibitory effects of silver nanoparticles against Newcastle disease virus in vitro[J].China Poultry, 2013, 35(15):14-17.(in Chinese). [13] DU T, LIANG J, DONG N, et al.Glutathione-capped Ag2S nanoclusters inhibit Coronavirus proliferation through blockage of viral RNA synthesis and budding[J]. ACS Applied Materials & Interfaces, 2018, 10(5):4369-4378. [14] LIU Z, LEI K, HAN G, et al.Novel Lentivirus-Based method for rapid selection of inhibitory nanobody against PRRSV[J]. Viruses, 2020, 12(2):229-244. [15] KOWALCZYK P, SZYMCZAK M, MACIEJEWSKA M, et al.All that glitters is not silver-A new look at microbiological and medical applications of silver nanoparticles[J]. International Journal of Molecular Sciences, 2021, 22(2):854-883. [16] JEREMIAH S S, MIYAKAWA K, MORITA T, et al.Potent antiviral effect of silver nanoparticles on SARS-CoV-2[J]. Biochemical and Biophysical Research Communications, 2020, 533(1):195-200. [17] MA J, MA L L, YANG M T, et al.The function of the PRRSV-host interactions and their effects on viral replication and propagation in antiviral strategies[J]. Vaccines, 2021, 9(4):364-380. [18] YANG X X, LI C M, HUANG C Z.Curcumin modified silver nanoparticles for highly efficient inhibition of Respiratory syncytial virus infection[J]. Nanoscale, 2016, 8(5):3040-3048. [19] CASTRO-MAYORGA J L, RANDAZZO W, FABRA M J, et al.Antiviral properties of silver nanoparticles against Norovirus surrogates and their efficacy in coated polyhydroxyalkanoates systems[J]. Food Science & Technology, 2017, 79(1):503-510. |